Related Experiment Video
Updated: Jun 8, 2026

Rapid Genotyping of Animals Followed by Establishing Primary Cultures of Brain Neurons
Published on: January 29, 2015
Direct interaction between causative genes of DYT1 and DYT6 primary dystonia
Sophie Gavarini1, Corinne Cayrol, Tania Fuchs
1Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York 10029, USA.
Abstract:
Primary dystonia is a movement disorder characterized by sustained muscle contractions and in which dystonia is the only or predominant clinical feature. TOR1A(DYT1) and the transcription factor THAP1(DYT6) are the only genes identified thus far for primary dystonia. Using electromobility shift assays and chromatin immunoprecipitation (ChIP) quantitative polymerase chain reaction (qPCR), we demonstrate a physical interaction between THAP1 and the TOR1A promoter that is abolished by pathophysiologic mutations. Our findings provide the first evidence that causative genes for primary dystonia intersect in a common pathway and raise the possibility of developing novel therapies targeting this pathway.
Insights
Researchers found that the THAP1 protein interacts with the TOR1A gene promoter in primary dystonia. This interaction is disrupted by disease-causing mutations, suggesting a shared pathway for these dystonia genes.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Primary dystonia is a movement disorder with sustained muscle contractions.
- TOR1A(DYT1) and THAP1(DYT6) are the only known causative genes for primary dystonia.
- The molecular mechanisms linking these genes remain largely unknown.
Purpose of the Study:
- To investigate the potential interaction between the THAP1 and TOR1A genes.
- To determine if pathophysiologic mutations affect this interaction.
- To explore a common pathway for primary dystonia genes.
Main Methods:
- Electromobility shift assays (EMSA) were used to detect protein-DNA interactions.
- Chromatin immunoprecipitation (ChIP) followed by quantitative polymerase chain reaction (qPCR) was employed.
- Analysis focused on the interaction between THAP1 and the TOR1A promoter region.
Main Results:
- A direct physical interaction between the transcription factor THAP1 and the TOR1A gene promoter was demonstrated.
- Pathophysiologic mutations in THAP1 or TOR1A abolished this physical interaction.
- This finding provides the first evidence of a shared molecular pathway involving primary dystonia genes.
Conclusions:
- The THAP1 protein physically interacts with the TOR1A promoter, suggesting a functional link between these primary dystonia genes.
- Mutations associated with primary dystonia disrupt this interaction, highlighting a common pathogenic pathway.
- This discovery opens avenues for novel therapeutic strategies targeting the identified pathway.
More Related Videos
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
10:05Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
Published on: January 27, 2018
Related Concept Videos
Epistasis Analysis
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Sex-linked Disorders
Alterations in Muscle Tone ll
Genetic Lingo